BLTE
Belite Bio
BLTE
BLTE
17 hedge funds and large institutions have $8.12M invested in Belite Bio in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
17
Holders Change
+10
Holders Change %
+142.86%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$2.05M |
| 2 |
AC
2
Armistice Capital
New York
|
$1.65M |
| 3 |
CSS
3
Cubist Systematic Strategies
Stamford,
Connecticut
|
$772K |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$733K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$653K |
Top Sellers
| 1 |
AWS
1
Atria Wealth Solutions
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$15.9K |
| 3 |
3
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$0 |
